[Clinical significance of the distinction of CD56 positive angiocentric lymphoma by REAL classification].
Ogura
M
M
Nakamura
S
S
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D019002:CD56 Antigen; D003131:Combined Modality Therapy; D006801:Humans; D008223:Lymphoma / Q000145:classification* / Q000188:drug therapy / Q000276:immunology; D011379:Prognosis; D015996:Survival Rate
D019002:CD56 Antigen